ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,715
0,61%
Bitcoin
66 963,91
2,64%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. RVL Pharmaceuticals PLC (RVLP)

  7. RVL Pharmaceuticals PLC (RVLP) Actualités

RVLP RVL Pharmaceuticals PLC

0,0282
0,00 (0,00%)
Dernière mise à jour : 02:00:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
RVL Pharmaceuticals PLC RVLP NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 0,0282 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,0282
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/1/202422:05EDGAR2Form 8-K - Current report
20/12/202322:15EDGAR2Form 8-K - Current report
27/11/202312:50GLOBERVL Completes Financial Restructuring
16/11/202315:11EDGAR2Form DEF 14A - Other definitive proxy statements
01/11/202321:27EDGAR2Form SC 13D/A - General statement of acquisition of..
23/10/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/10/202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202323:00EDGAR2Form 8-K - Current report
20/10/202321:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/10/202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202322:00EDGAR2Form 144 - Report of proposed sale of securities
13/10/202323:28EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202322:15EDGAR2Form 8-K - Current report
12/10/202312:50GLOBERVL Pharmaceuticals plc Announces Prepackaged Reorganization..
29/9/202322:05EDGAR2Form 8-K - Current report
22/9/202322:05EDGAR2Form 8-K - Current report
05/9/202322:18EDGAR2Form DEF 14A - Other definitive proxy statements
05/9/202322:06EDGAR2Form 8-K - Current report
05/9/202313:45EDGAR2Form SC 13D - General statement of acquisition of beneficial..
31/8/202320:23EDGAR2Form D - Notice of Exempt Offering of Securities
25/8/202323:21EDGAR2Form PRE 14A - Other preliminary proxy statements
25/8/202322:17EDGAR2Form 8-K - Current report
23/8/202323:30EDGAR2Form S-3 - Registration statement under Securities Act of..
23/8/202322:05GLOBERVL Pharmaceuticals plc to Present at the H.C. Wainwright..
18/8/202322:06EDGAR2Form 8-K - Current report
17/8/202323:06EDGAR2Form SC 13D/A - General statement of acquisition of..
17/8/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202322:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/8/202314:00GLOBERVL Pharmaceuticals plc Announces $5 Million Registered..
14/8/202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:51EDGAR2Form 8-K - Current report
14/8/202312:50GLOBERVL Pharmaceuticals plc Reports Second Quarter 2023..
02/8/202323:00EDGAR2Form 8-K - Current report
02/8/202314:30GLOBERVL Pharmaceuticals plc to Discuss Second Quarter 2023..
12/7/202303:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/7/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202312:50GLOBERVL Pharmaceuticals plc Provides Business Update
15/6/202322:15GLOBERVL Pharmaceuticals plc Announces Result of Proposal to..

Dernières Valeurs Consultées

NASDAQ
RVLP
RVL Pharmaceuticals
EU
ARVAG
Arval Service Lease SA 4...
USOTC
CUBXD
CubicFarm Systems (PK)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés